ABEIXI™
标准物质
| DB05-121 | Potassium Phosphate pH 7.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB05-10L | Potassium Phosphate pH 7.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DBC05-960 | Potassium Phosphate pH 7.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC05-250 | Potassium Phosphate pH 7.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC05-230 | Potassium Phosphate pH 7.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DB125-10 | Simulated Gastric Fluid (M) pH 1.20 Dissolution Media |
| DB12-121 | Simulated Gastric Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB12-10 | Simulated Gastric Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB12-07 | Simulated Gastric Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DBC12-960 | Simulated Gastric Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC12-250 | Simulated Gastric Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC12-230 | Simulated Gastric Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DB13-121 | Simulated Intestinal Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DBC13-960 | Simulated Intestinal Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC13-250 | Simulated Intestinal Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC13-230 | Simulated Intestinal Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| NAACUSP1 | Sodium Acetate pH 5.0 Dissolution Media |
| DB36-10 | Sodium Dodecyl Sulphate 0.1% w/v in 0.1M Hydrochloric Acid Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB07-121-25L | Sodium Lauryl Sulphate 0.50% Dissolution Media in accordance to United States Pharmacopoeia (USP) |
| DB07-121 | Sodium Lauryl Sulphate 0.50% Dissolution Media in accordance to United States Pharmacopoeia (USP) |
| DBC07-500 | Sodium Lauryl Sulphate 0.50% Dissolution Media in accordance to United States Pharmacopoeia (USP) Concentrate |
| DBC07-400 | Sodium Lauryl Sulphate 0.50% Dissolution Media in accordance to United States Pharmacopoeia (USP) Concentrate |
| DBC07-1L | Sodium Lauryl Sulphate 0.50% Dissolution Media in accordance to United States Pharmacopoeia (USP) Concentrate |
| DB09-121 | Sodium Phosphate pH 6.8 Dissolution Media in accordance to United States Pharmacopoeia (USP) |
| DBC09-960 | Sodium Phosphate pH 6.80 Dissolution Media in accordance to United States Pharmacopoeia (USP) Concentrate |
| DBC09-250 | Sodium Phosphate pH 6.80 Dissolution Media in accordance to United States Pharmacopoeia (USP) Concentrate |
| DBC09-230 | Sodium Phosphate pH 6.80 Dissolution Media in accordance to United States Pharmacopoeia (USP) Concentrate |
| REANC10 | ICP, ICP-MS Multi Element Standard (10 Elements) in 5% Nitric Acid (HNO₃) and 1% Hydrofluoric Acid (HF), ICH Q3D |
| REICPCAL10AN | ICP, ICP-MS Multi Element Standard (10 Elements) in 5-10% Nitric Acid (HNO₃), ICH Q3D |
| REICPUSP1 | ICP, ICP-MS Multi Element Standard (10 Elements) in 7% Nitric Acid (HNO₃), USP 232/233 |
| REAINHAL2A3 | ICP, ICP-MS Multi Element Standard (3 Elements) in 2% Nitric Acid (HNO₃), ICH Q3D Inhalation Class 2A |
| REAINHAL2B3M2 | ICP, ICP-MS Multi Element Standard (3 Elements) in 2% Nitric Acid (HNO₃), ICH Q3D Inhalation Class 2B |
| REAORAL2A3 | ICP, ICP-MS Multi Element Standard (3 Elements) in 2% Nitric Acid (HNO₃), ICH Q3D Oral Class 2A |
| REAORAL2B3M2 | ICP, ICP-MS Multi Element Standard (3 Elements) in 2% Nitric Acid (HNO₃), ICH Q3D Oral Class 2B |
| REAPAR2A3 | ICP, ICP-MS Multi Element Standard (3 Elements) in 2% Nitric Acid (HNO₃), ICH Q3D Parenteral Class 2A |
| REAPAR2B3M2 | ICP, ICP-MS Multi Element Standard (3 Elements) in 2% Nitric Acid (HNO₃), ICH Q3D Parenteral Class 2B |
| REAORAL33M2 | ICP, ICP-MS Multi Element Standard (3 Elements) in 5% Nitric Acid (HNO₃), trace Tartaric Acid (C₄H₆O₆) and Hydrofluoric Acid (HF), ICH Q3D Oral Class 3 |
| REAORAL34M1 | ICP, ICP-MS Multi Element Standard (4 Elements) in 10% Nitric Acid (HNO₃), ICH Q3D Oral Class 3 |
| REAINHAL14 | ICP, ICP-MS Multi Element Standard (4 Elements) in 5% Nitric Acid (HNO₃), ICH Q3D Inhalation Class 1 |
| REAORAL14 | ICP, ICP-MS Multi Element Standard (4 Elements) in 5% Nitric Acid (HNO₃), ICH Q3D Oral Class 1 |
| REAPAR14 | ICP, ICP-MS Multi Element Standard (4 Elements) in 5% Nitric Acid (HNO₃), ICH Q3D Parenteral Class 1 |
| REICPUSP7 | ICP, ICP-MS Multi Element Standard (4 Elements) in 7% Nitric Acid (HNO₃), USP 2232 Dietary Supplements |
| REICPUSP2 | ICP, ICP-MS Multi Element Standard (6 Elements) in 15% Hydrochloric Acid (HCl), USP 232 Precious Metal Impurities B (with Os) |
| REICPUSPIV | ICP, ICP-MS Multi Element Standard (6 Elements) in 15% Hydrochloric Acid (HCl), USP 232 Preparation for Parental Dose |
| REAPAR2B7M1 | ICP, ICP-MS Multi Element Standard (7 Elements) in 10% Hydrochloric Acid (HCl), ICH Q3D Parenteral Class 2B |
| REAORAL2B7M1 | ICP, ICP-MS Multi Element Standard (7 Elements) in 15% Hydrochloric Acid (HCl), ICH Q3D Oral Class 2B |
| REAINHAL37 | ICP, ICP-MS Multi Element Standard (7 Elements) in 2% Nitric Acid (HNO₃), trace Tartaric Acid (C₄H₆O₆) and Hydrofluoric Acid (HF), ICH Q3D Inhalation Class 3 |
| REAPAR37 | ICP, ICP-MS Multi Element Standard (7 Elements) in 2% Nitric Acid (HNO₃), trace Tartaric Acid (C₄H₆O₆) and Hydrofluoric Acid (HF), ICH Q3D Parenteral Class 3 |
| REICPCAL7M | ICP, ICP-MS Multi Element Standard (7 Elements) in 2-5% Nitric Acid (HNO₃) and trace Hydrofluoric Acid (HF), ICH Q3D |
| REICPUSP6 | ICP, ICP-MS Multi Element Standard (8 Elements) in 7% Nitric Acid (HNO₃), USP 232 Oral |
| REICPUSP3 | ICP, ICP-MS Multi Element Standard (8 Elements) in 7% Nitric Acid (HNO₃), USP 232 Parenteral |